{xtd_wp_head}
Skip to content
About
Meet the Team at CURF

The CURF team has a broad background and depth of experience guiding new technologies from concept to commercialization.

+ Meet Our Team

Technology
Search All Available Technologies from CURF

Browse a full library of technologies available for commercialization.

+ Search Available Tech

Innovators
Ready to disclose your invention to CURF?

Submit an Invention Disclosure through the CURF Inventor Portal.

+ Disclose Your Invention

Students
Now Accepting Graduate Interns 

Apply for our internship program at the Clemson University Research Foundation.

+ Apply Now

Industry
Search our library of Available Technologies

Looking for a technology or invention to commercialize?

+ Search Available Tech

View on Technology Publisher Site

Keywords: Computer Software, Biotechnology, Drug Discovery

Market Overview

Hypothesis generation is becoming a crucial technique that allows researchers to make connects between concepts. Typically, the systems operate on domain-specific fractions of public medical data. There are many unknown connections in the biomedical sciences. In order to fill the gaps in existing biomedical knowledge, Clemson University researchers have developed MOLIERE, which utilizes information from over 24.5 million historic documents including scientific papers, keywords, genes, proteins, diseases and diagnoses. MOLIERE will propose a possible connection between biomedical objects that are not known to be related to one another.
Ilya Safro
2020-028

Applications:

Biomedical Discovery, Data Analysis

Technical Summary Advantages

Technical Summary:

This technology has a multi-modal and multi-relational network of biomedical objects extracted from several heterogeneous datasets from the National Center for Biotechnology Information. MOLIERE models hypotheses using Latent Dirichlet Allocation applied on abstracts found near shortest paths discovered within the network. Effectiveness is demonstrated by performing hypothesis generation on historical data.

Advantages:

• Has a different algorithmic procedure from existing technology.
• Has massive validation results.
• Potentially can be used in the drug discovery pipeline.

Download Printable PDF

Technology Overview

State of Development

Prototype

Category

Biotechnology

CURF Reference No.

2020-028

Inventors

Ilya Safro

For More Info, Contact:

Andy Bluvas

Technology Commercialization Officer  bluvasa@clemson.edu

Contact

Contact

All Technologies

Get Started
Ready to Get Started?

Contact our team at CURF

Contact CURF